Rallybio Corporation Profile Avatar - Palmy Investing

Rallybio Corporation

Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a…

Biotechnology
US, New Haven [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Rallybio Corporation has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Rallybio Corporation can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Rallybio Corporation.

End of RLYB's Analysis
CIK: 1739410 CUSIP: 75120L100 ISIN: US75120L1008 LEI: - UEI: -
Secondary Listings
RLYB has no secondary listings inside our databases.